Search
JCVI Policy Center forecasts US likely to remain biotechnology leader through 2050, but China could threaten position
LA JOLLA, CA—July 28, 2021—The J. Craig Venter Institute (JCVI) Policy Center has released a summary version of their report outlining the competitive landscape of biotechnology through 2050. The report uses nearly 100 indicators to build scoring around a nation’s capacity and potential to invent and produce biotechnology products over time. While they forecast that the United States will continue to lead the world in biotechnology ahead of China, it is by no means assured. “By...
RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
LEXINGTON, MASSACHUSETTS, U.S.A., October 30, 2008 — RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, today announced that the J. Craig Venter Institute (JCVI), a not for profit genomic research organization located in Rockville, MD and La Jolla, CA, will become an early access partner for its new RDT 1000 instrument and Sequence Enrichment application. Under the Early Access Partner program,...
JCVI Researchers Collaborate on Sequence and Analysis of First Pennate Diatom Genome
LA JOLLA, CA — October 15, 2008 — The genome of Phaeodactylum tricornutum has been sequenced and analyzed by a large international team of researchers led by U.S. Department of Energy Joint Genome Institute (DOE JGI) and the Ecole Normale Supérieure of Paris. The group also includes scientists from the J. Craig Venter Institute. The team was led by first author Chris Bowler, Ph.D., of the Ecole Normale Supérieure, and published results in the October 15 edition of Nature....
Synthetic genomics advances and promise
LA JOLLA, CA and ROCKVILLE, MD—July 21, 2022—While the term synthetic biology was coined in the 1970s (by renowned geneticist, Waclaw Szybalski), its true emergence as a discipline did not happen until the late 1990s, into the 2000s. Key advances in knowledge, techniques, and technology gave rise to synthetic genomics, a branch of synthetic biology that constructs viruses, bacteria, and eukaryotic cells with synthetic genomes. These advances paved the way for diverse applications,...
Ruggles Family Foundation and Mr. and Mrs. Rudy L. Ruggles, Jr. Make $1.25M Donation to J. Craig Venter Institute for New Study to Identify and Elucidate Healthy Aging Biomarkers
ROCKVILLE, Md. and LA JOLLA, Calif. — Aug. 28, 2013 — The J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, today announced that the Ruggles Family Foundation and Mr. and Mrs. Rudy L. Ruggles, Jr. have made a $1.25 million donation to JCVI to identify and study biomarkers associated with healthy aging. As part of the four year grant, JCVI will collaborate with the Western Connecticut Health Network (WCHN), located...
137 Marine Microbial Genomes from Cultured Samples are Sequenced and Compared to Sorcerer II Global Ocean Expedition Samples by Researchers at J. Craig Venter Institute
ROCKVILLE, MD and SAN DIEGO, CA — November 3, 2010 — Researchers at the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, published results today describing the sequencing and analysis of 137 marine microbial genomes living in the global ocean surface. The research was published by JCVI lead authors Shibu Yooseph and Kenneth Nealson and colleagues in Nature. The results give clearer insights into life in this region of the ocean by showing that...
JCVI Scientists along with International Team of Researchers Sequence the Genome of Model Legume, Medicago
ROCKVILLE, MD — (November 16, 2011) — Scientists from the J. Craig Venter Institute (JCVI), along with a team of international researchers led by those at the University of Minnesota, have sequenced and published a draft genome of the model legume, Medicago truncatula, also known by its common name, "barrel medic". The results of this multi-year project were published this week in the online edition of the journal Nature. JCVI researchers, led by Christopher Town, Ph.D., played...
Groundbreaking study reveals oral microbiome’s role in immune response and COVID-19 severity
La Jolla, California—April 18, 2024—The human mouth is teaming with organisms collectively referred to as “the oral microbiome.” A growing body of evidence shows that in healthy individuals, the oral microbiome acts as a critical first line of defense against unwanted bacteria, viruses, and other pathogens that enter our mouths, including the virus that causes COVID-19. The human microbiome has a direct relationship with the immune system. In a newly published study, a team of...
Researchers design tools to develop vaccines more efficiently for African swine fever virus (ASFV)
Rockville, Maryland—March 26, 2024—Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock Research Institute (ILRI) have developed a reverse-genetics system for African swine fever virus (ASFV). This new system will aid researchers in developing vaccines and in studying the pathogenesis and biology of ASFV, a highly contagious, deadly viral disease affecting domesticated and wild pigs, especially prevalent in Africa,...
Influenza A Virus Discovered in Heart Muscle Tissue Causing Damage Long After It Has Cleared from the Lungs
(Rockville, Maryland)—January 27, 2021—Scientists from the J. Craig Venter Institute (JCVI) have discovered that Influenza A virus (IAV) is found in heart tissue after it has been cleared from the lungs in mouse models. Live IAV present during convalescence does not actively replicate, preventing development of antiviral inflammatory responses, thus cloaking it from the immune system. Undetected, the virus continues to disrupt mitochondrial function, causing a metabolic breakdown and...